Related references
Note: Only part of the references are listed.Pyruvate kinase M2 regulates glucose metabolism by functioning as a coactivator for hypoxia-inducible factor 1 in cancer cells
Weibo Luo et al.
Oncotarget (2015)
Risk Factors for Early Recurrence of HBV-related Hepatocellular Carcinoma Meeting Milan Criteria after Curative Resection
Wen-Jiang Zhu et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
Epidemiology and Survival of Hepatocellular Carcinoma in North-east Peninsular Malaysia
Bachok Norsa'adah et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
Risk Factors for Early and Late Intrahepatic Recurrence in Patients with Single Hepatocellular Carcinoma Without Macrovascular Invasion after Curative Resection
Shu-Hong Li et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
Epidemiology of Hepatocellular Carcinoma Consider the Population
Sahil Mittal et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2013)
Pyruvate Kinase M2 Plays a Dual Role on Regulation of the EGF/EGFR Signaling via E-Cadherin-Dependent Manner in Gastric Cancer Cells
Le-Yi Wang et al.
PLOS ONE (2013)
Clinical Significance of Axin and β-catenin Protein Expression in Primary Hepatocellular Carcinomas
Cheng-Nong Guan et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
Long-term Prognosis in Hepatocellular Carcinoma Patients after Hepatectomy
Lei Zhou et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
Trends in Incidence of Hepatocellular Carcinoma, 1990-2009, Khon Kaen, Thailand
Surapon Wiangnon et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
Biomarkers in Hepatocellular Carcinoma-Letter
Nicola Personeni et al.
CLINICAL CANCER RESEARCH (2012)
Pyruvate Kinase M2: Multiple Faces for Conferring Benefits on Cancer Cells
Mayumi Tamada et al.
CLINICAL CANCER RESEARCH (2012)
Hepatocellular Carcinoma Confirmation, Treatment, and Survival in Surveillance, Epidemiology, and End Results Registries, 1992-2008
Sean F. Altekruse et al.
HEPATOLOGY (2012)
Pyruvate kinase type M2 is upregulated in colorectal cancer and promotes proliferation and migration of colon cancer cells
Cheng-Fu Zhou et al.
IUBMB LIFE (2012)
Epithelial-mesenchymal transition and the liver: Role in hepatocellular carcinoma and liver fibrosis
Tina Maheswaran et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2012)
Pyruvate Kinase M2 Regulates Gene Transcription by Acting as a Protein Kinase
Xueliang Gao et al.
MOLECULAR CELL (2012)
ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect
Weiwei Yang et al.
NATURE CELL BIOLOGY (2012)
Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1
Weibo Luo et al.
CELL (2011)
Hepatocyte growth factor upregulation promotes carcinogenesis and epithelial-mesenchymal transition in hepatocellular carcinoma via Akt and COX-2 pathways
Olorunseun O. Ogunwobi et al.
CLINICAL & EXPERIMENTAL METASTASIS (2011)
PKM2 and the Tricky Balance of Growth and Energy in Cancer
Andrew N. Macintyre et al.
MOLECULAR CELL (2011)
Beta-catenin signaling, liver regeneration and hepatocellular cancer: Sorting the good from the bad
Kari Nichole Nejak-Bowen et al.
SEMINARS IN CANCER BIOLOGY (2011)
β-catenin signaling involves HGF-enhanced HepG2 scattering through activating MMP-7 transcription
Fei-Yan Pan et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2010)
Epithelial-Mesenchymal Transition and Cell Cooperativity in Metastasis
Takanori Tsuji et al.
CANCER RESEARCH (2009)
Pyruvate kinase isoenzyme M2 is a glycolytic sensor differentially regulating cell proliferation, cell size and apoptotic cell death dependent on glucose supply
Gilles A. Spoden et al.
EXPERIMENTAL CELL RESEARCH (2009)
EGF-Induced ERK Activation Promotes CK2-Mediated Disassociation of α-Catenin from β-Catenin and Transactivation of β-Catenin
Haitao Ji et al.
MOLECULAR CELL (2009)
Epidermal growth factor receptor expression and gene copy number in conventional hepatocellular carcinoma
Anne F. Buckley et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2008)
Molecular targeted therapies in hepatocellular carcinoma
Josep M. Llovet et al.
HEPATOLOGY (2008)
Pyruvate kinase isozyme type M2 (PKM2) interacts and cooperates with Oct-4 in regulating transcription
Jungwoon Lee et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)
Epithelial-mesenchymal transition events during human embryonic stem cell differentiation
Angela M. Eastham et al.
CANCER RESEARCH (2007)
PDGF essentially links TGF-β signaling to nuclear β-catenin accumulation in hepatocellular carcinoma progression
A. N. M. Fischer et al.
ONCOGENE (2007)
Phosphorylation of β-catenin by AKT promotes β-catenin transcriptional activity
Dexing Fang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Epithelial-mesenchymal transition and tumour invasion
Marcello Guarino
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2007)
Epidermal growth factor receptor:: A novel target of the Wnt/β-catenin pathway in liver
XP Tan et al.
GASTROENTEROLOGY (2005)
TGF-β1-promoted epithelial-to-mesenchymal transformation and cell adhesion contribute to TGF-β1-enhanced cell migration in SMMC-7721 cells
Z Xu et al.
CELL RESEARCH (2003)
Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion
ZM Lu et al.
CANCER CELL (2003)
EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma
D Liu et al.
CANCER CELL (2002)
The transcription factor Snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression
A Cano et al.
NATURE CELL BIOLOGY (2000)
Share Paper
